Profilo di rischio cardiovascolare nei pazienti con psoriasi
Daniela Di Lisi, Salvatore Novo(AOL (United States)), Mariacristina Meschisi(University of Palermo), Maria Rita Bongiorno(University of Palermo), Angelica Peritore(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesca Macaione, Francesco Cuttitta(University of Palermo), Egle Corrado(AOL (United States)), Giuseppina Novo(AOL (United States)), Francesca Bonura(University of Palermo)
Cited by 5
Related Papers
An Update on the Role of Markers of Inflammation in Atherosclerosis
|Journal of Atherosclerosis and Thrombosis|2010|196
Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*
|British Journal of Dermatology|2020|175
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
|Frontiers in Physiology|2018|154
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
|Antioxidants and Redox Signaling|2017|122